GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sequana Medical NV (GREY:SQNMF) » Definitions » Earnings per Share (Diluted)

Sequana Medical NV (Sequana Medical NV) Earnings per Share (Diluted) : $0.00 (TTM As of Jun. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Sequana Medical NV Earnings per Share (Diluted)?

Sequana Medical NV's Earnings per Share (Diluted) for the three months ended in Jun. 2023 was $0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00.

Sequana Medical NV's EPS (Basic) for the three months ended in Jun. 2023 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00.

Sequana Medical NV's EPS without NRI for the three months ended in Jun. 2023 was $0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00.

During the past 3 years, the average EPS without NRIGrowth Rate was -2.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was -14.20% per year.

During the past 9 years, Sequana Medical NV's highest 3-Year average EPS without NRI Growth Rate was -2.50% per year. The lowest was -27.60% per year. And the median was -6.60% per year.


Sequana Medical NV Earnings per Share (Diluted) Historical Data

The historical data trend for Sequana Medical NV's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequana Medical NV Earnings per Share (Diluted) Chart

Sequana Medical NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only -1.17 -1.36 -1.52 -1.47 -1.43

Sequana Medical NV Quarterly Data
Dec15 Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sequana Medical NV's Earnings per Share (Diluted)

For the Medical Devices subindustry, Sequana Medical NV's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sequana Medical NV's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sequana Medical NV's PE Ratio distribution charts can be found below:

* The bar in red indicates where Sequana Medical NV's PE Ratio falls into.



Sequana Medical NV Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Sequana Medical NV's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2022 is calculated as

Diluted Earnings Per Share (A: Dec. 2022 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-32.588-0)/22.770
=-1.43

Sequana Medical NV's Earnings Per Share (Diluted) for the quarter that ended in Jun. 2023 is calculated as

Diluted Earnings Per Share (Q: Jun. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-17.837-0)/25.308
=-0.70

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Sequana Medical NV  (GREY:SQNMF) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Sequana Medical NV Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Sequana Medical NV's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Sequana Medical NV (Sequana Medical NV) Business Description

Comparable Companies
Traded in Other Exchanges
Address
Kortrijksesteenweg 1112 ,bus 102, Sint-Denijs-Westrem, Ghent, BEL, 9051
Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies and over 750 implants. The company's geographical segments include Switzerland, Germany, the United Kingdom, and the Rest of the world, out of which Germany accounts for the majority of the revenue.

Sequana Medical NV (Sequana Medical NV) Headlines

No Headlines